Tumor Predisposing Post-Zygotic Chromosomal Alterations in Bladder Cancer-Insights from Histologically Normal Urothelium

Bladder urothelial carcinoma (BLCA) is the 10th most common cancer with a low survival rate and strong male bias. We studied the field cancerization in BLCA using multi-sample- and multi-tissue-per-patient protocol for sensitive detection of autosomal post-zygotic chromosomal alterations and loss of chromosome Y (LOY). We analysed 277 samples of histologically normal urothelium, 145 tumors and 63 blood samples from 52 males and 15 females, using the in-house adapted Mosaic Chromosomal Alterations (MoChA) pipeline. This approach allows identification of the early aberrations in urothelium from BLCA patients. Overall, 45% of patients exhibited at least one alteration in at least one normal urothelium sample. Recurrence analysis resulted in 16 hotspots composed of either gains and copy number neutral loss of heterozygosity (CN-LOH) or deletions and CN-LOH, encompassing well-known and new BLCA cancer driver genes. Conservative assessment of LOY showed 29%, 27% and 18% of LOY-cells in tumors, blood and normal urothelium, respectively. We provide a proof of principle that our approach can characterize the earliest alterations preconditioning normal urothelium to BLCA development. Frequent LOY in blood and urothelium-derived tissues suggest its involvement in BLCA.

Citing Articles

The effects of loss of Y chromosome on male health.

Bruhn-Olszewska B, Markljung E, Rychlicka-Buniowska E, Sarkisyan D, Filipowicz N, Dumanski J Nat Rev Genet. 2025; .

PMID: 39743536 DOI: 10.1038/s41576-024-00805-y.

A complex systems approach to mosaic loss of the Y chromosome.

Guo X, Dai X Geroscience. 2024; 47(1):631-651.

PMID: 39680277 PMC: 11872822. DOI: 10.1007/s11357-024-01468-7.

The impact of mosaic loss of the Y chromosome (mLOY) in men of advanced age.

Abou Abdallah F, Abdel Massih C, Attieh C, Chebly A Biogerontology. 2024; 25(6):943-955.

PMID: 39223433 DOI: 10.1007/s10522-024-10133-7.

Loss of the Y Chromosome: A Review of Molecular Mechanisms, Age Inference, and Implications for Men's Health.

Gutierrez-Hurtado I, Sanchez-Mendez A, Becerra-Loaiza D, Rangel-Villalobos H, Torres-Carrillo N, Gallegos-Arreola M Int J Mol Sci. 2024; 25(8).

PMID: 38673816 PMC: 11050192. DOI: 10.3390/ijms25084230.

References

Hoglund M . On the origin of syn- and metachronous urothelial carcinomas. Eur Urol. 2006; 51(5):1185-93. DOI: 10.1016/j.eururo.2006.11.025. View

Haitjema S, Kofink D, van Setten J, van der Laan S, Schoneveld A, Eales J . Loss of Y Chromosome in Blood Is Associated With Major Cardiovascular Events During Follow-Up in Men After Carotid Endarterectomy. Circ Cardiovasc Genet. 2017; 10(4):e001544. DOI: 10.1161/CIRCGENETICS.116.001544. View

Jaiswal S, Ebert B . Clonal hematopoiesis in human aging and disease. Science. 2019; 366(6465). PMC: 8050831. DOI: 10.1126/science.aan4673. View

Wang C, Ross W, Mysorekar I . Urothelial generation and regeneration in development, injury, and cancer. Dev Dyn. 2017; 246(4):336-343. PMC: 5354960. DOI: 10.1002/dvdy.24487. View

Forsberg L, Rasi C, Malmqvist N, Davies H, Pasupulati S, Pakalapati G . Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer. Nat Genet. 2014; 46(6):624-8. PMC: 5536222. DOI: 10.1038/ng.2966. View

Moran J, Kim H, Li Z, Moreno C . SOX4 regulates invasion of bladder cancer cells via repression of WNT5a. Int J Oncol. 2019; 55(2):359-370. PMC: 6615919. DOI: 10.3892/ijo.2019.4832. View

Bruhn-Olszewska B, Davies H, Sarkisyan D, Juhas U, Rychlicka-Buniowska E, Wojcik M . Loss of Y in leukocytes as a risk factor for critical COVID-19 in men. Genome Med. 2022; 14(1):139. PMC: 9747543. DOI: 10.1186/s13073-022-01144-5. View

Smeets W, Pauwels R, Laarakkers L, Debruyne F, Geraedts J . Chromosomal analysis of bladder cancer. III. Nonrandom alterations. Cancer Genet Cytogenet. 1987; 29(1):29-41. DOI: 10.1016/0165-4608(87)90028-8. View

Fiala C, Diamandis E . Mutations in normal tissues-some diagnostic and clinical implications. BMC Med. 2020; 18(1):283. PMC: 7594459. DOI: 10.1186/s12916-020-01763-y. View

10.

Loftfield E, Zhou W, Graubard B, Yeager M, Chanock S, Freedman N . Predictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank. Sci Rep. 2018; 8(1):12316. PMC: 6098142. DOI: 10.1038/s41598-018-30759-1. View

11.

Wojcik M, Juhas U, Mohammadi E, Mattisson J, Drezek-Chyla K, Rychlicka-Buniowska E . Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases. Sci Rep. 2024; 14(1):9458. PMC: 11043399. DOI: 10.1038/s41598-024-60049-y. View

12.

Sauter G, Moch H, Mihatsch M, Gasser T . Molecular cytogenetics of bladder cancer progression. Eur Urol. 1998; 33 Suppl 4:9-10. DOI: 10.1159/000052252. View

13.

Czerniak B, Dinney C, McConkey D . Origins of Bladder Cancer. Annu Rev Pathol. 2016; 11:149-74. DOI: 10.1146/annurev-pathol-012513-104703. View

14.

Vermeulen M, Pearse R, Young-Pearse T, Mostafavi S . Mosaic loss of Chromosome Y in aged human microglia. Genome Res. 2022; 32(10):1795-1807. PMC: 9712627. DOI: 10.1101/gr.276409.121. View

15.

Forsberg L, Halvardson J, Rychlicka-Buniowska E, Danielsson M, Moghadam B, Mattisson J . Mosaic loss of chromosome Y in leukocytes matters. Nat Genet. 2018; 51(1):4-7. DOI: 10.1038/s41588-018-0267-9. View

16.

Dumanski J, Halvardson J, Davies H, Rychlicka-Buniowska E, Mattisson J, Moghadam B . Immune cells lacking Y chromosome show dysregulation of autosomal gene expression. Cell Mol Life Sci. 2021; 78(8):4019-4033. PMC: 8106578. DOI: 10.1007/s00018-021-03822-w. View

17.

Kinoshita Y, Singh A, Rovito Jr P, Wang C, Haas G . Double primary cancers of the prostate and bladder: a literature review. Clin Prostate Cancer. 2004; 3(2):83-6. DOI: 10.3816/cgc.2004.n.016. View

18.

Zhou W, Machiela M, Freedman N, Rothman N, Malats N, Dagnall C . Reply to 'Mosaic loss of chromosome Y in leukocytes matters'. Nat Genet. 2018; 51(1):7-9. PMC: 8366411. DOI: 10.1038/s41588-018-0310-x. View

19.

Filipowicz N, Drezek K, Horbacz M, Wojdak A, Szymanowski J, Rychlicka-Buniowska E . Comprehensive cancer-oriented biobanking resource of human samples for studies of post-zygotic genetic variation involved in cancer predisposition. PLoS One. 2022; 17(4):e0266111. PMC: 8989288. DOI: 10.1371/journal.pone.0266111. View

20.

Lee-Six H, Olafsson S, Ellis P, Osborne R, Sanders M, Moore L . The landscape of somatic mutation in normal colorectal epithelial cells. Nature. 2019; 574(7779):532-537. DOI: 10.1038/s41586-019-1672-7. View